Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jerald C. Sadoff"'
Autor:
Thomas L. Hale, Genevieve Losonsky, Karen L. Kotloff, David N. Taylor, Steven S. Wasserman, Myron M. Levine, James P. Nataro, Jerald C. Sadoff
Publikováno v:
Vaccine. 13:1488-1494
In the absence of a definitive immunologic correlate of protection against shigellosis, promising Shigella vaccine candidates have been selected based on their ability to confer resistance against experimental challenge with wild-type Shigella in hea
Autor:
Emil Fürer, Andrew W. Artenstein, Jerald C. Sadoff, Alan S. Cross, J Stanley Cryz Jr, Terry Fredeking, John U. Que
Publikováno v:
Journal of Infectious Diseases. 170:834-840
Since a limited number of O serogroups account for nearly 70% of bacteremic and meningitic Escherichia coli isolates, a polyvalent vaccine was made by conjugating a Pseudomonas aeruginosa exotoxin A carrier protein to the O polysaccharide of 12 serog
Autor:
John U. Que, David N. Taylor, J B McClain, Alan S. Cross, Robert R. Edelman, Steven S. Wasserman, Jerald C. Sadoff, Stanley J. Cryz
Publikováno v:
Vaccine. 12:1288-1294
A Klebsiella (K) vaccine consisting of 24 capsular polysaccharide antigens and a Pseudomonas aeruginosa (P) vaccine consisting of eight O-polysaccharide antigens conjugated to P toxin A have been developed to prevent sepsis by means of active or pass
Autor:
C Chu, Shai Ashkenazi, J Shiloach, D Bryla, David N. Taylor, Y Lerman, Jerald C. Sadoff, W Egan, A C Trofa, D Cohen
Publikováno v:
Infection and Immunity. 61:3678-3687
The theoretic basis for developing conjugate vaccines, to induce immunoglobulin G (IgG) lipopolysaccharide (LPS) antibodies for the prevention of shigellosis, has been described (J. B. Robbins, C.-Y. Chu, and R. Schneerson, Clin. Infect. Dis. 15:346-
Autor:
James R. Bryan, Edmund C. Tramont, Jerald C. Sadoff, Daniel G. McChesney, Raymond T. Chung, Jennie Ciak, John W. Boslego, Charles C. Brinton, Joel D. Brown, Myron V. Piziak, Sarah W. Wood
Publikováno v:
Vaccine. 9:154-162
A randomized, placebo-controlled, double-blind efficacy trial of a purified gonococcal pilus vaccine composed of a single pilus type was tested in 3123 men and 127 women volunteers. Either 100 μg of vaccine or a placebo was given intradermally on da
Publikováno v:
Infection and Immunity. 58:373-377
Nontoxic, serologically reactive O polysaccharide was derived from Escherichia coli O18 lipopolysaccharide by acid hydrolysis, extraction with organic solvents, and gel filtration chromatography. Oxidized O polysaccharide was covalently coupled to ei
Autor:
Thomas L. Hale, Nadav Orr, Guy Robin, Danka Pavliakova, Jerald C. Sadoff, M. Yavzori, Manfred S. Green, Isaac Ashkenazi, Joshua Shemer, Michael Gdalevich, Rachel Schneerson, Colin Block, Dani Cohen, John B. Robbins, David N. Taylor, Shai Ashkenazi, Raphael Slepon
Publikováno v:
Lancet (London, England). 349(9046)
Summary Background The aim of this double-blind randomised vaccine-controlled trial was to assess the efficacy of a conjugate vaccine composed of Shigella sonnei O-specific polysaccharide bound to Pseudomonas aeruginosa recombinant exoprotein A ( S s
Autor:
Raphael Slepon, David N. Taylor, Jerald C. Sadoff, John B. Robbins, Shai Ashkenazi, Manfred S. Green, Chiayung Chu, Guy Robin, Nadav Orr, Yehuda Lerman, Dani Cohen, Joseph Shiloach, Rachel Schneerson
Publikováno v:
Scopus-Elsevier
Publons
Publons
The safety and immunogenicity of investigational conjugates, composed of the O-specific polysaccharides of Shigella sonnei and Shigella flexneri type 2a covalently bound to Pseudomonas aeruginosa recombinant exoprotein A (rEPA), were evaluated in 192
Autor:
Thomas L. Hale, Nadav Orr, Dani Cohen, Guy Robin, Jerald C. Sadoff, Raphael Slepon, Yehuda Lerman, Shai Ashkenazi, David N. Taylor, Michael Wiener, M. Yavzori, Manfred S. Green, Ruhama Ambar, Colin Block
Publikováno v:
Vaccine. 12(15)
A double-blind placebo-controlled study was carried out on the safety and immunogenicity of the oral Shigella flexneri (EcSf2a-2) vaccine among Israeli soldiers. Sixty volunteers received the vaccine and 59 received placebo. Fifty-three were given th
Autor:
Jim C. Williams, Jerald C. Sadoff, Rangarajan Badri Narayanan, Christopher R. Bolt, Joseph J. Drabick, Anne H. Fortier, Monte S. Meltzer, Carol A. Nacy
Publikováno v:
Journal of leukocyte biology. 53(1)
An IgM monoclonal antibody (mAb) recognized surface antigens specific to Francisella tularensis wild-type (Schu4) and live vaccine strain (LVS), and reacted with both in ELISA and slide agglutination tests. This mAb also reacted with LVS microorganis